´ëÇѾȽŰæÀÇÇÐȸ 2019³â Ãß°èÇмú´ëȸ - Neurology of eye movements : 2019-10-19±³À°ÀÏÀÚ : 2019-10-19
±³À°Àå¼Ò : ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀǽÇ
±³À°ÁÖÁ¦ :
´ëÇѾȽŰæÀÇÇÐȸ 2019³â Ãß°èÇмú´ëȸ - Neurology of eye movementsÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾȽŰæÀÇÇÐȸ
´ã´çÀÚ : ±èÀ¯Áø
¿¬¶ôó : 02-974-8606
À̸ÞÀÏ :
ksno2012@gmail.com ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 35ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í »çÀüµî·Ïºñ: Àü¹®ÀÇ 20,000, Àü°øÀÇ 10,000´çÀϵî·Ïºñ: Àü¹®ÀÇ 30,000, Àü°øÀÇ 20,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 09:10~09:35 Visual acuity and fields ÀÌÀͼº(¼øõÇâÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 09:35~10:05 Diplopia ¹ÚÁöÀ±(¿ï»êÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 10:05~10:35 Optical coherence tomography and FAG ÀÌÇàÁø(¼¿ïÀÇ´ë ¾È°ú)
Åä·Ð 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 10:35~10:40 Q & A ()
±âŸ 10-19 10:40~11:00 ÈÞ½Ä ()
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 11:00~11:15 Diagnostic criteria of MS and NMO ¹ÚÀçÇÑ(´ë±¸°¡Å縯ÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 11:15~11:30 Ocular motor dysfunction in MS and NMO À̼±¿í(°í·ÁÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 11:30~11:50 Optic neuropathy in MS and NMO ¿ÀÀºÇý(ºÎ»êÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 11:50~12:10 Autoantibodies in MS and NMO ÇöÀç¿ø(±¹¸³¾Ï¼¾ÅÍ ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 12:10~12:30 Treatment of MS and NMO Á¤ÀϾï(°í·ÁÀÇ´ë ½Å°æ°ú)
Åä·Ð 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 12:30~12:40 Q & A ()
½Ä»ç 10-19 12:40~13:50 Lunch ()
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 13:50~14:10 Optic disc swelling ±èÇö¾Æ(°è¸íÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 14:10~14:30 Traumatic optic neuropathy ÀÌ¿¬Èñ(Ãæ³²ÀÇ´ë ¾È°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 14:30~14:50 Retinal diseases mimicking optic neuropathy ½Å¼±¿µ(°¡Å縯ÀÇ´ë ¾È°ú)
Åä·Ð 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 14:50~15:00 Q & A ()
±âŸ 10-19 15:00~15:15 ÈÞ½Ä ()
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 15:15~15:30 HorizontalAperiodic Alternating Nystagmus ¹ÚÁöÀ±(¿ï»êÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 15:30~15:45 Altered resting-state functional connectivity in Wernicke¡¯s encephalopathy with vestibular impairment °ÁøÁÖ(ÀüºÏÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 15:45~16:00 Ocular motor characteristics ofoculopalatal tremor according to the pontine tegmental lesion ±èÀç¸í(Àü³²ÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 16:00~16:15 Machine learning prediction of recurrences in benign paroxysmal positionalvertigo Á¤¼ºÇØ(Ãæ³²ÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 10-19 ¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾î¸°À̺´¿ø ÀÓ»ó 1°ÀÇ½Ç 16:15~16:30 The Effect of Bbotulinum Toxin Therapy in Patients Affected by VestibularMigraine °ÁøÁÖ(ÀüºÏÀÇ´ë ½Å°æ°ú)